| P2093 | author name string | Chen Lin | |
| | Ping Ni | |
| | Kumar Sandrasegaran | |
| | Qun Zhong | |
| | Yuning Lin | |
| | Ziqian Chen | |
| P2860 | cites work | Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging | Q22065375 |
| | Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging | Q28251899 |
| | Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications. | Q30414447 |
| | Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology | Q30483058 |
| | Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron | Q30576890 |
| | Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging | Q30847288 |
| | Characterization of continuously distributed cortical water diffusion rates with a stretched‐exponential model | Q30881440 |
| | Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance | Q31136938 |
| | Diffusion weighted imaging in the liver | Q33547861 |
| | MRI quantification of non-Gaussian water diffusion by kurtosis analysis | Q33633190 |
| | Diffusion MR imaging for monitoring of treatment response | Q33762884 |
| | Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up | Q34048029 |
| | Assessment of multiexponential diffusion features as MRI cancer therapy response metrics | Q34249651 |
| | Intravoxel incoherent motion diffusion imaging of the liver: optimal b-value subsampling and impact on parameter precision and reproducibility | Q34622734 |
| | Water-fat separation in diffusion-weighted EPI using an IDEAL approach with image navigator. | Q35145768 |
| | Spatially constrained incoherent motion method improves diffusion-weighted MRI signal decay analysis in the liver and spleen. | Q35224926 |
| | Cardiac motion in diffusion-weighted MRI of the liver: artifact and a method of correction. | Q35656182 |
| | Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice | Q35676598 |
| | Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection | Q36166572 |
| | Diffusion-weighted imaging of the liver: technical challenges and prospects for the future | Q36423750 |
| | Single breath-hold diffusion-weighted MRI of the liver with parallel imaging: initial experience | Q36612437 |
| | Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults | Q36762937 |
| | Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging | Q37068523 |
| | Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 |
| | Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver | Q37168535 |
| | Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. | Q37383964 |
| | Diffusion-weighted MR imaging of the liver. | Q37661956 |
| | Diffusion-weighted MRI of the transplanted liver | Q37881345 |
| | Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease | Q37948739 |
| | Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. | Q38174810 |
| | Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. | Q38177763 |
| | Quantifying liver fibrosis through the application of texture analysis to diffusion weighted imaging | Q40150972 |
| | Assessment of diffusion-weighted imaging for characterizing focal liver lesions | Q41643069 |
| | Removal of olefinic fat chemical shift artifact in diffusion MRI. | Q42026986 |
| | A robust multi-shot scan strategy for high-resolution diffusion weighted MRI enabled by multiplexed sensitivity-encoding (MUSE). | Q42058839 |
| | Solid focal liver lesion characterisation with apparent diffusion coefficient ratios | Q43706701 |
| | Motion artifact reduction of diffusion-weighted MRI of the liver: use of velocity-compensated diffusion gradients combined with tetrahedral gradients | Q44067468 |
| | Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. | Q44206380 |
| | Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis | Q44688577 |
| | Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases | Q45064418 |
| | Quantitative liver ADC measurements using diffusion-weighted MRI at 3 Tesla: evaluation of reproducibility and perfusion dependence using different techniques for respiratory compensation | Q45344496 |
| | Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma | Q45737237 |
| | Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. | Q45823751 |
| | Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers | Q46080794 |
| | Comparison of the accuracy of diffusion-weighted imaging versus dynamic contrast enhancement magnetic resonance imaging in characterizing focal liver lesions | Q46477802 |
| | Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up | Q46746663 |
| | High resolution diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging and a two-dimensional navigator-based reacquisition. | Q48611154 |
| | Simultaneous Multislice Echo Planar Imaging With Blipped Controlled Aliasing in Parallel Imaging Results in Higher Acceleration: A Promising Technique for Accelerated Diffusion Tensor Imaging of Skeletal Muscle | Q48679023 |
| | Whole-liver diffusion-weighted MRI histogram analysis: effect of the presence of colorectal hepatic metastases on the remaining liver parenchyma. | Q50591505 |
| | Characterizing non-gaussian, high b-value diffusion in liver fibrosis: Stretched exponential and diffusional kurtosis modeling. | Q51139728 |
| | Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices: preliminary experience in fresh liver explants. | Q51341716 |
| | Usefulness of free-breathing readout-segmented echo-planar imaging (RESOLVE) for detection of malignant liver tumors: comparison with single-shot echo-planar imaging (SS-EPI). | Q51709362 |
| | Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. | Q51765607 |
| | Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. | Q51865136 |
| | Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. | Q51914314 |
| | Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. | Q53059807 |
| | Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. | Q53088820 |
| | T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations. | Q53094240 |
| | Diffusion-weighted MRI and optimal b-value for characterization of liver lesions. | Q53097292 |
| | Diffusion-weighted MRI and liver metastases. | Q53259902 |
| | Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma. | Q53532842 |
| | Diffusion-weighted imaging of the liver at 3 T using section-selection gradient reversal: emphasis on chemical shift artefacts and lesion conspicuity. | Q53645938 |
| | Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics. | Q55056587 |
| P433 | issue | 1 | |
| P304 | page(s) | 189-202 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Abdominal radiology (New York) | Q27727105 |
| P1476 | title | Technical advancements and protocol optimization of diffusion-weighted imaging (DWI) in liver | |
| P478 | volume | 41 | |